| 1 |
32711421 | Crocin Increases Gastric Cancer Cells' Sensitivity to Doxorubicin. | 2020 Jul 1 |
1 |
| 2 |
33364937 | Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein Inhibitors. | 2020 |
2 |
| 3 |
31199153 | NIR-Responsive Polypeptide Nanocomposite Generates NO Gas, Mild Photothermia, and Chemotherapy to Reverse Multidrug-Resistant Cancer. | 2019 Jul 10 |
1 |
| 4 |
30466608 | Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance. | 2018 Dec 1 |
1 |
| 5 |
28217977 | miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. | 2017 Jun |
1 |
| 6 |
25482933 | Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. | 2015 |
1 |
| 7 |
25586174 | Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. | 2015 May |
1 |
| 8 |
26407111 | Human ABCB1 confers cells resistance to cytotoxic guanidine alkaloids from Pterogyne nitens. | 2015 |
3 |
| 9 |
24284783 | β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. | 2014 Feb |
1 |
| 10 |
23466650 | Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. | 2013 Jun |
3 |
| 11 |
21835258 | The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. | 2012 Jan |
1 |
| 12 |
23301649 | [Proteins of resistance and drug resistance in ovarian carcinoma patients]. | 2012 |
1 |
| 13 |
20642825 | Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1. | 2010 Jul 19 |
1 |
| 14 |
19442043 | Discovery of 4-aryl-4H-chromenes as potent apoptosis inducers using a cell- and caspase-based Anti-cancer Screening Apoptosis Program (ASAP): SAR studies and the identification of novel vascular disrupting agents. | 2009 May |
1 |
| 15 |
19549389 | [Transfection of gene mdr1 into human bone marrow mesenchymal stem cells by lentiviral vector]. | 2009 Jun |
1 |
| 16 |
18673531 | Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy. | 2008 Aug 1 |
1 |
| 17 |
17441962 | Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. | 2007 Jul |
1 |
| 18 |
16728344 | Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer. | 2006 Jul-Aug |
1 |
| 19 |
16836929 | [The lethal effect of combined MDR1 antisense RNA with oxaliplatin and 5-FU on drug-resistant rectal carcinoma cells]. | 2006 Jun 1 |
1 |
| 20 |
14706143 | [The reverse effect on drug-resistance against tyrosine kinase inhibitor STI571 in mdr1 and bcr-abl positive leukemic cells]. | 2003 Dec |
1 |
| 21 |
11780384 | Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. | 2001 Sep |
1 |
| 22 |
11877073 | [Improvement of combination chemotherapy tolerance of human umbilical cord blood CD(34)(+) cells transducted with double drug resistance genes by a bicistronic retroviral vector]. | 2001 Apr |
1 |
| 23 |
11189514 | [The modulation effect of granulocyte-colony stimulating factor on the mdr1/P-gp expression in acute myeloid leukemic cells]. | 1998 Jul |
1 |
| 24 |
9009089 | Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. | 1997 Feb |
1 |
| 25 |
1348973 | Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein. | 1992 |
2 |
| 26 |
1687990 | Expression of the multidrug transporter P-glycoprotein and in vitro chemosensitivity: correlation with in vivo response to chemotherapy in acute myeloid leukemia. | 1991 Winter |
1 |